about
Biomarkers in autismLinks between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence.The neurobiology of autism.The serotonergic anatomy of the developing human medulla oblongata: implications for pediatric disorders of homeostasisA lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic childrenAutism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter (PMAT) gene.Investigation of signaling molecules and metabolites found in crustacean hemolymph via in vivo microdialysis using a multifaceted mass spectrometric platform.Low serum IgA and increased expression of CD23 on B lymphocytes in peripheral blood in children with regressive autism aged 3-6 years old.Brief report: normal intestinal permeability at elevated platelet serotonin levels in a subgroup of children with pervasive developmental disorders in Curaçao (The Netherlands antilles).Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses.Pleiotropic effects of neurotransmission during development: modulators of modularityMacrophage migration inhibitory factor and autism spectrum disordersA review of the serotonin transporter and prenatal cortisol in the development of autism spectrum disorders.Theoretical aspects of autism: biomarkers--a review.Association Between Atopic Dermatitis and Autism Spectrum Disorders: A Systematic Review.Microbiome and nutrition in autism spectrum disorder: current knowledge and research needs.Studies on regeneration of central nervous system and social ability of the earthworm Eudrilus eugeniae.Neurotransmitter systems and neurotrophic factors in autism: association study of 37 genes suggests involvement of DDC.Use of drawings in children with pervasive developmental disorder during hospitalization: a developmental perspective.
P2860
Q21129103-634D35E3-BB38-4AEF-9654-88DDE87D2DF0Q34047430-0BD55701-EAE8-4A34-ADD0-5402FDA4E988Q34699035-40C03C3F-7F42-464F-A170-4531BE60352EQ35098779-3ADEF89B-2D36-4BAF-B1A0-D32CB315A25FQ35123969-AD429D17-3222-4075-A834-D8D67F74D1E9Q35208018-532FEA77-309B-4F51-AAB0-6A011DB9871DQ35874615-FB4DD828-DC2E-4457-B01E-A2A940839513Q35990473-A9C72799-43A4-4799-BAE0-694C2C72E450Q36428700-73E9416C-707C-4076-A710-938A231E8ABAQ37068738-36272107-B7E9-4018-9E29-7408BCD2EF28Q37224539-0D35205E-1B53-4027-AC45-7E17BC480A9BQ37277595-9F998C49-166E-4E95-9773-54B4D85C6A06Q37366340-51252B28-07DF-4ADD-9C01-3B5754608F07Q37836872-9BDF94C1-930F-4DF5-9087-32401E2437B9Q38562758-D10EC8B0-FB1A-4291-A0F8-5B385AC88E4FQ38793435-D9023E55-7175-42D1-99D2-F31149F0156CQ39698237-13AAE46C-BB3B-471E-95BF-496E5B184220Q48625126-83066940-3AAA-4126-9B5A-653330ED59B7Q50766340-8B89D6E1-E567-4640-886A-0C8E1FA4C2E6
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Hyperserotoninemia and altered immunity in autism
@ast
Hyperserotoninemia and altered immunity in autism
@en
Hyperserotoninemia and altered immunity in autism
@nl
type
label
Hyperserotoninemia and altered immunity in autism
@ast
Hyperserotoninemia and altered immunity in autism
@en
Hyperserotoninemia and altered immunity in autism
@nl
prefLabel
Hyperserotoninemia and altered immunity in autism
@ast
Hyperserotoninemia and altered immunity in autism
@en
Hyperserotoninemia and altered immunity in autism
@nl
P2093
P2860
P1476
Hyperserotoninemia and altered immunity in autism
@en
P2093
Nancy K Burgess
Robert S Fujinami
Thayne L Sweeten
William M McMahon
P2860
P2888
P304
P356
10.1007/S10803-006-0100-7
P407
P577
2006-07-01T00:00:00Z
P6179
1051454570